This HTML5 document contains 154 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1053/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q41222268
rdf:type
wikibase:Item
schema:description
naučni članak სამეცნიერო სტატია บทความทางวิทยาศาสตร์ artigo científico наукова стаття, опублікована в травні 2015 2015年論文 videnskabelig artikel teaduslik artikkel 2015年の論文 tieteellinen artikkeli 2015年论文 bilimsel makale научная статья επιστημονικό άρθρο 2015年論文 2015年论文 artikulong pang-agham مقالة علمية نشرت في 15 مايو 2015 2015年论文 vitenskapelig artikkel wissenschaftlicher Artikel artikel ilmiah article científic scientific article published on 15 May 2015 научни чланак 2015年論文 article scientific мақолаи илмӣ научни чланак 2015年論文 tudományos cikk vetenskaplig artikel 2015年论文 articol științific vědecký článek vitskapeleg artikkel 2015年論文 artículo científico publicado en 2015 scientific article published on 15 May 2015 bài báo khoa học article scientifique artigo científico wetenschappelijk artikel ১৫ মে ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artykuł naukowy 2015년 논문 scientific article published on 15 May 2015 2015 nî lūn-bûn artículu científicu espublizáu en 2015 מאמר מדעי vedecký článok научна статия artigo científico scienca artikolo 2015年论文 2015年论文 artikull shkencor articolo scientifico
p:P577
wds:Q41222268-0792365A-02BE-47B9-9913-9744D378645C
wdt:P577
2015-05-15T00:00:00Z
p:P407
wds:Q41222268-972D9CB8-C181-4FE9-AE8B-074BB01292D8
wdt:P407
wd:Q1860
p:P2093
wds:Q41222268-ECE0CBAE-E7C8-4E49-95E5-44CC2BA02B48 wds:Q41222268-EFDEE594-EEF6-4BBE-A3C2-521F2BCC1763 wds:Q41222268-F4A8E5F3-D80E-494A-B55E-DA0F7C841A33 wds:Q41222268-78F78C22-7DE6-4E56-B801-73498C1B48D2 wds:Q41222268-77C688F5-94BD-44FE-B391-0327EDB13F9C wds:Q41222268-67E27E85-3207-41E6-9BAE-3EE41B6FCA94 wds:Q41222268-6B84F7E3-7066-45C2-8EF6-5E7EA64842F4 wds:Q41222268-609DAA75-C82D-4310-AD49-45151F0FB665 wds:Q41222268-A895EBA7-8205-4AB5-91C8-7A544DB55387 wds:Q41222268-80620240-F8BC-4B33-8884-D38F5A4C6F49 wds:Q41222268-88AD6E1E-0832-4F40-8366-F341D5A34143 wds:Q41222268-1E6874F7-55A8-4549-B843-AC84407B9B5F wds:Q41222268-13A428E4-AFE4-4B7F-A7D4-D7C6780B1E3F wds:Q41222268-0B9783D8-725B-4B6D-A450-564A58D93066 wds:Q41222268-048E2985-F501-4AD4-9447-30484DE4CBD8 wds:Q41222268-48CF88DC-B3D3-438D-B0C1-B07FE3E75DD9 wds:Q41222268-3EFBFDC2-F12C-45C8-8DFC-0F0275D0E841 wds:Q41222268-3516D109-2C23-4E03-9D4C-BB06BC035686 wds:Q41222268-2EEFB249-9CA7-4EA2-ADFB-5BC727924227 wds:Q41222268-E48B1D89-838B-416B-988C-E8B99538421E wds:Q41222268-48CF00AD-A93D-49E0-8101-E8227F2347EB wds:Q41222268-5A020954-6266-4F6F-A816-E2FE1FF38030
wdt:P2093
Paul Kwo Phillip S Pang Kimberly Brown Robert S Brown Andrew J Muir Surakit Pungpapong Gregory T Everson Steven L Flamm Robert J Fontana Eugene Schiff Theo Brandt-Sarif SOLAR-1 Investigators Lewis Teperman Sarah Arterburn Jacqueline G O'Leary Michael Charlton Michael W Fried Richard Gilroy Jill Denning Princy Kumar John G McHutchison Kevin M Korenblat
rdfs:label
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
skos:prefLabel
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
schema:name
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
p:P50
wds:Q41222268-A9BF85C9-85F6-45E4-8660-41E5A7BDD067 wds:Q41222268-AD57C075-2750-4584-89E0-46CD50535891 wds:Q41222268-72639CC5-AD53-4548-A66D-93A06B537C20 wds:Q41222268-7CBC974A-E9F5-4934-96A9-8565D9BCB00E wds:Q41222268-41DB1821-2221-4AE1-A121-B2A1D801ED68 wds:Q41222268-45DC45A9-E58D-47CE-BA75-D3D16F083D47 wds:Q41222268-288B79BF-121E-4D57-84AC-660D6B8210DC wds:Q41222268-EA1AEA6A-34BD-4065-ACE4-AB59C08516D4 wds:Q41222268-BE2E9BE5-2E4D-436E-B882-40650175124E
wdt:P50
wd:Q47158936 wd:Q61149573 wd:Q45342286 wd:Q69932454 wd:Q89040794 wd:Q61478982 wd:Q89653950 wd:Q60650815 wd:Q42979695
p:P1476
wds:Q41222268-90F2FDB8-55B8-4FF8-82B1-11A3307176FD
wdt:P1476
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
p:P304
wds:Q41222268-D05EFC45-1E91-4455-A385-B2CD3312EBF3
wdt:P304
649-659
p:P31
wds:Q41222268-BD07D904-CBA0-4025-8FE9-04C79A611BE9
wdt:P31
wd:Q13442814
p:P921
wds:Q41222268-B63736B8-AA39-44F5-89EF-65FED644F41D wds:Q41222268-2F8E50CB-1A3D-4DDA-AA33-6D3170BECFF9 wds:Q41222268-99D9B549-2A2A-4CEB-984B-AB2E94F55FD5
wdt:P921
wd:Q15409409 wd:Q421862 wd:Q2502747
p:P698
wds:Q41222268-C0F3F9B2-8104-45BC-A01F-CE2792125AA8
wdtn:P698
n8:25985734
wdt:P698
25985734
p:P1433
wds:Q41222268-49A4F090-508B-46A2-99DC-88777AB4D96B
wdt:P1433
wd:Q4039279
p:P433
wds:Q41222268-0B947B99-49D9-4873-B762-2C5266978126
p:P478
wds:Q41222268-DB4BC74A-BA22-45F6-BF37-B1EF7E3EF2DA
wdt:P433
3
wdt:P478
149
p:P356
wds:Q41222268-0EB4A7A0-1664-404C-B8E9-8E3165D5A613
wdtn:P356
n9:J.GASTRO.2015.05.010
wdt:P356
10.1053/J.GASTRO.2015.05.010
p:P5875
wds:Q41222268-1DF11031-2803-4134-A97E-C744ED549936
wdt:P5875
277083394